These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27693848)

  • 1. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptors by kynurenic acid.
    Mori Y; Mouri A; Kunisawa K; Hirakawa M; Kubota H; Kosuge A; Niijima M; Hasegawa M; Kurahashi H; Murakami R; Hoshi M; Nakano T; Fujigaki S; Fujigaki H; Yamamoto Y; Nabeshima T; Saito K
    Behav Brain Res; 2021 May; 405():113191. PubMed ID: 33607168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.
    Parrott JM; Redus L; Santana-Coelho D; Morales J; Gao X; O'Connor JC
    Transl Psychiatry; 2016 Oct; 6(10):e918. PubMed ID: 27754481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
    Mouri A; Hasegawa M; Kunisawa K; Saito K; Nabeshima T
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):233-237. PubMed ID: 36990795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.
    Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ
    J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat.
    Wang J; Li X; He S; Hu L; Guo J; Huang X; Hu J; Qi Y; Chen B; Shang D; Wen Y
    J Ethnopharmacol; 2018 Mar; 214():13-21. PubMed ID: 29217494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice.
    Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K
    Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
    Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
    J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
    Kubota H; Kunisawa K; Niijima M; Hirakawa M; Mori Y; Hasegawa M; Fujigaki S; Fujigaki H; Yamamoto Y; Saito K; Nabeshima T; Mouri A
    Biochem Biophys Res Commun; 2022 Nov; 629():142-151. PubMed ID: 36116377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.
    Duda W; Curzytek K; Kubera M; Connor TJ; Fagan EM; Basta-Kaim A; Trojan E; Papp M; Gruca P; Budziszewska B; Leśkiewicz M; Maes M; Lasoń W
    Int Immunopharmacol; 2019 Aug; 73():527-538. PubMed ID: 31176083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xiaochaihutang attenuates depressive/anxiety-like behaviors of social isolation-reared mice by regulating monoaminergic system, neurogenesis and BDNF expression.
    Ma J; Wang F; Yang J; Dong Y; Su G; Zhang K; Pan X; Ma P; Zhou T; Wu C
    J Ethnopharmacol; 2017 Aug; 208():94-104. PubMed ID: 28687505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway.
    Wang B; Lian YJ; Su WJ; Peng W; Dong X; Liu LL; Gong H; Zhang T; Jiang CL; Wang YX
    Brain Behav Immun; 2018 Aug; 72():51-60. PubMed ID: 29195782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women.
    Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ
    J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.
    Erhardt S; Pocivavsek A; Repici M; Liu XC; Imbeault S; Maddison DC; Thomas MAR; Smalley JL; Larsson MK; Muchowski PJ; Giorgini F; Schwarcz R
    Biol Psychiatry; 2017 Nov; 82(10):756-765. PubMed ID: 28187857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice.
    Bay-Richter C; Janelidze S; Sauro A; Bucala R; Lipton J; Deierborg T; Brundin L
    J Neuroinflammation; 2015 Sep; 12():163. PubMed ID: 26338025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.
    Laumet G; Zhou W; Dantzer R; Edralin JD; Huo X; Budac DP; O'Connor JC; Lee AW; Heijnen CJ; Kavelaars A
    Brain Behav Immun; 2017 Nov; 66():94-102. PubMed ID: 28709913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
    Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
    Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenine 3-monooxygenase limits de novo NAD
    Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ
    Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
    Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
    Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
    Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
    Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.